ADIPOQ and allergic asthma: A similar reduction in BAL inflammatory cells as well as reductions in BAL eotaxin and IL-13 with adiponectin overexpression was observed (Figure 4) when we used a chronic OVA challenge protocol in which inflammation is dependent on mast cells [31], a feature relevant to human allergic asthma.